<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ911121-0173</DOCNO><DOCID>911121-0173.</DOCID><HL>   OTC Focus:   Shares Advance Despite Profit-Taking;   Index Moves Up 0.51% as Trading Slows   ----   By Dave Pettit   Staff Reporter of The Wall Street Journal</HL><DATE>11/21/91</DATE><SO>WALL STREET JOURNAL (J), PAGE C6</SO><IN>STOCK INDEXES (NDX)OTC GENERAL MARKET COMMENT (OTC)STOCK MARKET, OFFERINGS (STK)U.S. STOCK MARKET STATISTICS (STT)</IN><NS>STOCK AND OTHER INDEXES (NDX)STOCK andamp; OTHER MARKET NEWS (STK)</NS><RE>NORTH AMERICA (NME)UNITED STATES (US)</RE><LP>   NEW YORK -- Over-the-counter stocks edged higher yesterdaybut continued profit-taking set a low ceiling on the market'sgains.   Stocks bounced around at higher levels throughout thesession under the influence of sellers locking in paperprofits, and other investors buying stocks they believed werecheap after sharp sell-offs Friday and Tuesday.</LP><TEXT>   The Nasdaq Composite Index never slipped into negativeterritory yesterday. It closed with a gain of 2.65, or 0.51%,to 526.12. However, the index had been up 4.50 earlier.Advancing issues outpaced decliners, 1,278 to 802.   The OTC market fell 11 points, or 2%, on Tuesday. Friday,it plunged 24 points, or 4%.   Prices closed lower on the Big Board. The New York StockExchange Composite Index finished with a loss of 0.48, or0.23%, while the Dow Jones Industrial Average slipped 1.56,or 0.05%.   Trading activity, meanwhile, slipped significantly fromits recent pace. National Market System volume totaled amoderately active 133,760,000 shares, compared with an active182,560,000 Tuesday.   The most active Nasdaq stock was Autodesk. Shares of theSausalito, Calif., software developer plunged 5 1/2, or 14%,to 33 on volume of 3.2 million shares after the companyposted somewhat lower-than-expected third-quarter earnings.   As a whole, it was a mixed day for computer technology andbiotechnology stocks, which together have led the marketrecently. Intel slipped 1/2 to 41 1/4 on a heavy 2.1 millionshares, while Amgen gained 1/2 to 56 3/4 on 1.7 millionshares. Among others, Microsoft added 1/4 to 96 1/2, Biogenjumped 3 to 41 1/4 and Apple Computer slid 3/4 to 50 1/2.   &quot;I think this is a very nervous market. This market needsa little time to get its confidence back,&quot; said Barry Berman,head of equity trading at Robert W. Baird andamp; Co. Lookingahead, he said, &quot;You can make a very bullish scenario and areally bearish scenario, and I'm hearing both.&quot;   Despite the market's upside finish, E.E. Geduld, presidentof Herzog Heine Geduld Inc., said he saw more profit-takingthan buying yesterday. &quot;We are a month and a half from theend of the year, and especially in the stocks where there arebig profits, people are looking to lock them in,&quot; he said.   MCI Communications was also active, adding 7/8 to 26 3/4.George Dellinger, an analyst at County NatWest, upgraded hisinvestment rating on the stock to &quot;accumulate&quot; from &quot;hold.&quot;The analyst cited recent declines in the stock's price andhis increasing optimism about MCI's prospects in competingwith American Telephone andamp; Telegraph.   &quot;I'm increasingly convinced that this company is the bestpositioned to confront the two remaining risks that remain infront of ATandamp;T's competitors,&quot; Mr. Dellinger said. Theserisks, he said, are further deregulation of ATandamp;T's businessand competition between the long-distance telephone concernsover the technologies they use.   Autodesk's shares slumped after it said late Tuesday thatits third-quarter net totaled 65 cents a share. While thatwas above the 63 cents a share the company earned last year,it was below the mean analyst estimate of 67 cents a share,according to First Call, a unit of Thomson FinancialNetworks.   Yesterday, several analysts reduced their forecasts forAutodesk's fourth-quarter earnings to a range of 63 cents to65 cents a share, compared with previous projections of 69cents a share, Dow Jones Professional Investor Report said.   Two companies had successful initial public offerings.Insurance Auto Auctions closed at 14 on 1.7 million shares,well above its offering price of $11 a share. GenCare HealthSystems finished at its offering price of $10 on 770,000shares.   Insurance Auto's offering was made at the top end of itsexpected $9-to-$11 range. The size of the issue was increasedby about 140,000 shares, to 2,080,000. The Los Angelescompany provides services designed to help insurancecompanies sell vehicles that have been damaged by accidentsor theft.   GenCare Health's three million-share issue, meanwhile, wasreduced from the 3.2 million shares that were initiallyplanned. The health maintenance organization operator'soffering was priced near the middle of its expected range.   Elsewhere, Genelabs Technologies gained 3/4 to 10 1/4after the company said it received a U.S. patent for itsdiagnostic reagents that are designed to be used in detectingHTLV-I infections. HTLV-I is a human retrovirus that cancause cancers and myelopathy, a neurological disorder.   Akorn slipped 3/8 to 2 3/8. The company recorded a loss of$43,000 for the first quarter, ended Sept. 30, compared withyear-ago net income of $288,000, or three cents a share.Additionally, Akorn suspended payment of dividends.   Air Wis Services added 7/8 to 10. Late Tuesday, AMR Corp.and its American Airlines unit filed a lawsuit alleging thatUAL Corp.'s agreement to acquire Air Wis violates antitrustand securities laws. AMR has offered to buy some of Air Wis'sassets at Chicago's O'Hare International Airport. Air Wisgave AMR until noon today to come up with a better bid forsome of its assets.   U.S. Bancorp added 5/8 to 18 5/8. Kemper Securitiesanalyst Lawrence Vitale issued a &quot;strong buy&quot; recommendationon shares of the Portland, Ore., bank, Dow Jones ProfessionalInvestor Report said.   ImmuLogic Pharmaceutical jumped 1 to 17 1/4 before beinghalted following news that it entered a preliminary agreementunder which Marion Merrell Dow will purchase one million ofits shares for $18 apiece. Marion Merrell Dow and ImmuLogicwill jointly develop and sell ImmuLogic's Allervax allergytherapeutics. Trading in ImmuLogic shares didn't resumeyesterday.   Lincoln Financial lost 2 to 18. The Fort Wayne, Ind., banksaid its board will defer its decision on whether to pay afourth-quarter dividend until next month. In October, thecompany made a 22-cent-a-share payout.</TEXT></DOC>